<DOC>
	<DOCNO>NCT02256761</DOCNO>
	<brief_summary>The study comprise two part . The objective first study period ass safety pharmacokinetics 500 mg BIRT 2584 XX tablet administer without food male healthy volunteer determine relative bioavailability BIRT 2584 XX tablet formulation compare historical comparison BIRT 2584 XX powder PEG 400 ( U05-2074 ) ( part 1 ) . The second major phase trial aim evaluate safety , tolerability , pharmacokinetics , pharmacodynamics multiple rise dos BIRT 2584 XX ( 100 mg , 250 mg , 500 mg bid first 2 day qd follow 12 day , 750 mg qd 28 day ) healthy male subject ( part 2 )</brief_summary>
	<brief_title>Safety , Pharmacokinetics , Pharmacodynamics BIRT 2584 XX Administered Multiple Doses Safety Pharmacokinetics BIRT 2584 XX Administered With Without Food Single Dose Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male subject determine result screen Signed write informed consent accordance Good Clinical Practice ( GCP ) local legislation Age ≥ 18 ≤ 63 year BMI ≥ 18.5 ≤ 29.9 kg/m2 Any finding medical examination ( include blood pressure , pulse rate , electrocardiogram ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic , hematological , oncological , hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder Relevant history orthostatic hypotension , faint spell , blackout Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) consider relevant trial judge investigator Intake drug long halflife ( great 24 hour ) ( less 1 month prior administration trial ) Use drug , might influence result trial ( le 10 day prior study drug administration expect trial ) Participation another trial investigational drug ( le 2 month prior administration expect trial ) Smoker ( 10 cigarettes/day 3 cigars/day 3 pipes/day ) Alcohol abuse ( 60 g ethanol per day ) Drug abuse Blood donation loss great 400 mL ( less 1 month prior administration expect trial ) Clinically relevant laboratory abnormality</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>63 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>